Desq Long
Sign in

Company

ZEVRA THERAPEUTICS, INC.

ZVRA · CIK 0001434647

SEC FORM 4
$474,774.45

ZEVRA THERAPEUTICS, INC. (ZVRA)

Sale of 42,666 shares at $11.1277 per share.

Reporting Person Thompson Rahsaan · Officer Title Chief Legal & Compliance · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001434647-26-000073 · filed 2026-08-17 · View filing →

SEC FORM 4
$61,131.00

ZEVRA THERAPEUTICS, INC. (ZVRA)

Acquisition (code M) of 12,300 shares at $4.97 per share.

Reporting Person Watton Corey Michael · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001434647-26-000070 · filed 2026-08-12 · View filing →

SEC FORM 4
$138,377.46

ZEVRA THERAPEUTICS, INC. (ZVRA)

Sale of 12,300 shares at $11.2502 per share.

Reporting Person Watton Corey Michael · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001434647-26-000070 · filed 2026-08-12 · View filing →